the glucagon thing finally clicked for me and I want to write it down
Thinking out loud about this: the glucagon thing finally clicked for me and I want to write it down. Read the phase 2 paper twice before ordering anything. Recommend that to anyone in this board: the error bars are the interesting part. Kept a log specifically because there is so little published. It is one person…
The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.
heart rate is the thing people report watching
heart rate is the thing people report watching
Agreed, and the glucagon arm is exactly why the comparison threads do not work.
What is the source for that figure — the published paper or a summary of it?
Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer.
Glucagon receptor agonism is associated with increased energy expenditure and with hepatic effects. That is a mechanistic story with strong preclinical support and limited phase 2 human data.
dose escalation in the trials was slow for a reason